Skip to main content

Advertisement

Fig. 4 | Clinical and Translational Allergy

Fig. 4

From: Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AIT

Fig. 4

Bet v 1-specific β-hexosaminidase release during AIT analyzed by mediator release assays. a Therapy-related changes in mediator release triggered by 10 ng/ml Bet v 1. Statistics were performed with Friedman and Dunn’s post test. b Correlation of mediator release with RTSS. Serum samples were obtained at three different time points (T0, open; T1, semi-filled; T2, filled symbols)

Back to article page